These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 16267070

  • 1. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.
    Pedersen OD, Abildstrøm SZ, Ottesen MM, Rask-Madsen C, Bagger H, Køber L, Torp-Pedersen C, TRACE Study Investigators.
    Eur Heart J; 2006 Feb; 27(3):290-5. PubMed ID: 16267070
    [Abstract] [Full Text] [Related]

  • 2. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P.
    Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
    [Abstract] [Full Text] [Related]

  • 3. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L.
    Int J Cardiol; 2005 Sep 30; 104(2):184-9. PubMed ID: 16168812
    [Abstract] [Full Text] [Related]

  • 4. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.
    Pedersen OD, Bagger H, Køber L, Torp-Pedersen C, TRACE Study Group.
    Int J Cardiol; 2005 Apr 08; 100(1):65-71. PubMed ID: 15820287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
    N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219
    [Abstract] [Full Text] [Related]

  • 8. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
    Scardi S, Mazzone C, Pandullo C, Goldstein D, Di Lenarda A, Chersevani D.
    G Ital Cardiol; 1999 Jun 21; 29(6):637-46. PubMed ID: 10396667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
    Dasari TW, Pavlovic-Surjancev B, Patel N, Williams AA, Ezidinma P, Rupani A, Sinacore JL, Heroux AL.
    Am J Cardiol; 2010 Sep 01; 106(5):737-41. PubMed ID: 20723655
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Apr 05; 122(7):802-6. PubMed ID: 19493393
    [Abstract] [Full Text] [Related]

  • 12. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
    Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS, OPTIMAAL investigators.
    Eur Heart J; 2005 Feb 05; 26(4):350-6. PubMed ID: 15618041
    [Abstract] [Full Text] [Related]

  • 13. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.
    Tapanainen JM, Lindgren KS, Mäkikallio TH, Vuolteenaho O, Leppäluoto J, Huikuri HV.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):757-63. PubMed ID: 14998613
    [Abstract] [Full Text] [Related]

  • 14. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, Tsurumi Y, Koyanagi R, Kasanuki H, Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators.
    Heart; 2009 Mar 03; 95(3):216-20. PubMed ID: 18728065
    [Abstract] [Full Text] [Related]

  • 15. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
    Aliot E.
    Arch Mal Coeur Vaiss; 1996 Aug 03; 89 Spec No 3():23-31. PubMed ID: 8949315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ, Chung MJ, Gheorghiade M, Pang PS, Kwasny MJ, Ambrosy AP, Vaduganathan M, O'Connor CM, Swedberg K, Zannad F, Konstam MA, Maggioni AP.
    Am Heart J; 2012 Dec 03; 164(6):884-92.e2. PubMed ID: 23194489
    [Abstract] [Full Text] [Related]

  • 19. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H, Andersson T, Fengsrud E, Friberg L, Linde P, Rosenqvist M, Englund A.
    J Intern Med; 2011 Sep 03; 270(3):281-90. PubMed ID: 21635583
    [Abstract] [Full Text] [Related]

  • 20. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
    Luria DM, Hodge DO, Monahan KH, Haroldson JM, Shen WK, Asirvatham SJ, Hammill SC, Munger TM, Glikson M, Gersh BJ, Packer DL, Friedman PA.
    J Cardiovasc Electrophysiol; 2008 Nov 03; 19(11):1145-50. PubMed ID: 18554204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.